4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-19-041725
Director sold 10,000 shares at $34.63 ($346,300)
- Director acquired 10,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Lingnau Lutz Director | 2019-07-08 | Option exercise | +10,000 | $9.24 | $92,400 | 33,200 | D: show line 1 in the form |
| Lingnau Lutz Director | 2019-07-08 | Sale | −10,000 | $34.63 | $346,300 | 23,200 | D: show line 2 in the form |
| Open-market sales · 10,000 sh · avg $34.63 · $346,300 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Lingnau Lutz Director | 2019-07-08 | Option exercise · Stock Option | −10,000 | 0 | D: show line 3 in the form |
Loading xslF345X03/doc4.xml…